Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.
Journal Information
Full Title: Pathology
Abbreviation: Pathology
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest and sources of funding: Katerina Dvorak and John Palting are currently employed by Ventana Medical Systems Inc. Birte Aggeler is a former employee of Ventana Medical Systems Inc. Paul Waring received research funding from Ventana Medical Systems Inc. to support this study. He is also a former consultant for Roche and former employee of Genentech, a Roche company. Dr Penny McKelvie and Dr Andrew Ruszkiewicz report no conflicts of interest."
"Conflicts of interest and sources of funding: Katerina Dvorak and John Palting are currently employed by Ventana Medical Systems Inc. Birte Aggeler is a former employee of Ventana Medical Systems Inc. Paul Waring received research funding from Ventana Medical Systems Inc. to support this study. He is also a former consultant for Roche and former employee of Genentech, a Roche company. Dr Penny McKelvie and Dr Andrew Ruszkiewicz report no conflicts of interest."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025